Intriguingly, the removal of this branched N-glycans on CRC cells could expose immunogenic glycan epitopes to enhance recognition by immune cells via DC-SIGN and potentiate an effective antitumor immune response (166). The gene discussed is CD209; the disease is colorectal carcinoma.